Psikobiyotikler ve Şizofreni

Yılmaz K, Karlı K. Bağırsak Mikrobiyotası ve Gastrointestinal Sistem Hastalıklarında Probiyotiklerin Mikrobiyotaya Etkisi. Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2023; 2(2): 29-41.doi:10.59778/sbfdergisi.1314182

Mandal RS, Saha S, Das S. Metagenomic surveys of gut microbiota. Genomics Proteomics Bioinformatics. 2015;13(3):148-158. doi:10.1016/j.gpb.2015.02.005

Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology. 2020;11:25. doi:10.3389/fendo.2020.00025

Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenteroloy. 2015;28(2):203-209.

Ekici M, Baş-Ekici H. Beyin-bağırsak-mikrobiyota ekseni: Genel bakış. Bozok Veterinary Sciences. 2021; 2(1):16-22.

Dinan TG, Cryan JF. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterology Clinics of North America. 2017;46(1):77-89. doi:10.1016/j.gtc.2016.09.007

Simpson CA, Diaz-Arteche C, Eliby D, et al. The gut microbiota in anxiety and depression - A systematic review. Clinical Psychology Review. 2021;83:101943. doi:10.1016/j.cpr.2020.101943

Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences. 2013;36(5):305-312. doi:10.1016/j.tins.2013.01.005

Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain, Behaviour, and Immunity. 2014;38:1-12. doi:10.1016/j.bbi.2013.12.015

Liu JCW, Gorbovskaya I, Hahn MK, et al. The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment. Nutrients. 2021;13(4):1152. doi:10.3390/nu13041152

Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biological Psychiatry. 2013;74(10):720-726. doi:10.1016/j.biopsych.2013.05.001

Cheng LH, Liu YW, Wu CC, et al. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. Journal of Food anf Drug Analysis. 2019;27(3):632-648. doi:10.1016/j.jfda.2019.01.002

Morshedi M, Hashemi R, Moazzen S, et al Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review. Journal of Neuroinflammation. 2019;16(1):231.doi:10.1186/s12974-019-1611-4

Sarkar A, Lehto SM, Harty S, et al. Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals. Trends in Neurosciences. 2016;39(11):763-781. doi:10.1016/j.tins.2016.09.002

Vasiliu O. The current state of research for psychobiotics use in the management of psychiatric disorders-A systematic literature review. Frontiers in Psychiatry. 2023;14:1074736. doi:10.3389/fpsyt.2023.1074736

World Gastroenterology Organisation. Global guidelines probiotics and prebiotics 2023. (20.02.2024 tarihinde www.worldgastroenterology.org adresinden ulaşılmıştır).

17.Wasilewski A, Zielińska M, Storr M, et al. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2015;21(7):1674-1682. doi:10.1097/MIB.0000000000000364

Douglas LC, Sanders ME. Probiotics and prebiotics in dietetics practice [published correction appears in J Am Diet Assoc. 2008 Aug;108(8):1381]. Journal of the American Dietetic Association. 2008;108(3):510-521. doi:10.1016/j.jada.2007.12.009

Del Toro-Barbosa M, Hurtado-Romero A, Garcia-Amezquita LE, et al. Psychobiotics: Mechanisms of Action, Evaluation Methods and Effectiveness in Applications with Food Products. Nutrients. 2020;12(12):3896. doi:10.3390/nu12123896

Frei R, Akdis M, O'Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Current Opinion in Gastroenterology. 2015;31(2):153-158. doi:10.1097/MOG.0000000000000151

Kartalcı Ş. Şizofreni etyolojisinde mikrobiyotanın rolü. Psikiyatride Güncel Yaklaşımlar. 2018; 10(2):265-278.doi:10.18863/pgy.358105

Bradley AJ, Dinan TG. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. Journal of Psychopharmacology. 2010;24(4 Suppl):91-118. doi:10.1177/1359786810385491

Ait-Belgnaoui A, Colom A, Braniste V, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterology and Motiityl. 2014;26(4):510-520. doi:10.1111/nmo.12295

Andersson H, Tullberg C, Ahrné S, et al. Oral Administration of Lactobacillus plantarum 299v Reduces Cortisol Levels in Human Saliva during Examination Induced Stress: A Randomized, Double-Blind Controlled Trial. International Journal of Microbiology. 2016;2016:8469018. doi:10.1155/2016/8469018

Misra S, Mohanty D. Psychobiotics: A new approach for treating mental illness?. Critical Reviews in Food Science and Nutrition. 2019;59(8):1230-1236. doi:10.1080/10408398.2017.1399860

Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Procedings of the National Academy of Sciences of the United States of America. 2010;107(27):12204-12209. doi:10.1073/pnas.0909122107

Shanahan F. The colonic microflora and probiotic therapy in health and disease. Current Opinion in Gastroenterology. 2011;27(1):61-65. doi:10.1097/MOG.0b013e328340076f

Kartalci S, Karabulut AB, Erbay LG, et al. Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia. The Journal of ECT. 2016;32(3):174-179. doi:10.1097/YCT.0000000000000303

Na KS, Jung HY, Kim YK. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Progress in Neuro-psychopharmacology&Biological Psychiatry. 2014;48:277-286. doi:10.1016/j.pnpbp.2012.10.022

Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophrenia Research. 2016;176(1):23-35. doi:10.1016/j.schres.2014.06.027

Torrey EF, Bartko JJ, Lun ZR, et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin. 2007;33(3):729-736. doi:10.1093/schbul/sbl050

Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of Stress. 2017;7:124-136. doi:10.1016/j.ynstr.2017.03.001

O'Mahony SM, Clarke G, Borre YE, et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research. 2015;277:32-48. doi:10.1016/j.bbr.2014.07.027

Özyürek MB, Özcan T. Psikobiyotik etki mekanizmaları ve bağırsak mikrobiyotası. Uluslararası Bilim, Teknoloji ve Tasarım Dergisi. 2020; 1(1): 59-77.

Wall R, Cryan JF, Ross RP, et al. Bacterial neuroactive compounds produced by psychobiotics. Advances in Experimental Medicine Biology. 2014;817:221-239. doi:10.1007/978-1-4939-0897-4_10

Tapia-Arancibia L, Rage F, Givalois L, et al. Physiology of BDNF: focus on hypothalamic function. Frontiers in Neuroendocrinology. 2004;25(2):77-107. doi:10.1016/j.yfrne.2004.04.001

Kazak F, Yarım GF. Nörotrofinler. Kocatepe Veteriner Dergisi. 2014; 7(1):47-57.doi:10.5578/kvj.7239

Maqsood R, Stone TW. The Gut-Brain Axis, BDNF, NMDA and CNS Disorders. Neurochemical Research. 2016;41(11):2819-2835. doi:10.1007/s11064-016-2039-1

Bistoletti M, Caputi V, Baranzini N, et al. Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice. PloS One. 2019;14(2):e0212856. doi:10.1371/journal.pone.021285

Tian P, O'Riordan KJ, Lee YK, et al. Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiology of Stress. 2020;12:100216. doi:10.1016/j.ynstr.2020.100216

Savignac HM, Corona G, Mills H, et al. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochemistry International. 2013;63(8):756-764. doi:10.1016/j.neuint.2013.10.006

Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189-200. doi:10.1080/19490976.2015.1134082

Sherwin E, Rea K, Dinan TG, et al. A gut (microbiome) feeling about the brain. Current Opinion in Gastroenterology. 2016;32(2):96-102. doi:10.1097/MOG.0000000000000244

Desbonnet L, Garrett L, Clarke G, et al. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. Journal of Psychiaty Research. 2008;43(2):164-174. doi:10.1016/j.jpsychires.2008.03.009

Gilbert JA, Krajmalnik-Brown R, Porazinska DL, et al. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell. 2013;155(7):1446-1448. doi:10.1016/j.cell.2013.11.035

Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399(10323):473-486. doi:10.1016/S0140-6736(21)01730-X

Taşkın Uyan T, Köroğlu A, Hocaoğlu Ç. Şizofreni: Etiyoloji, tanı ve tedavi yaklaşımlarında güncel durum. ERÜ Sağlık Bilimleri Dergisi. 2023; 10(1):19-35.

Müller N, Schwarz MJ. Immune System and Schizophrenia. Current Immunology Reviews. 2010;6(3):213-220. doi:10.2174/157339510791823673

Nguyen TT, Kosciolek T, Eyler LT, et al. Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. Journal of Psychiatric Research. 2018;99:50-61. doi:10.1016/j.jpsychires.2018.01.013

Prestwood TR, Asgariroozbehani R, Wu S, et al. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behavioural Brain Research. 2021;402:113101. doi:10.1016/j.bbr.2020.113101

Zhu S, Jiang Y, Xu K, et al. The progress of gut microbiome research related to brain disorders. Journal of Neuroinflammation. 2020;17(1):25. doi:10.1186/s12974-020-1705-z

Samochowiec J, Misiak B. Gut microbiota and microbiome in schizophrenia. Current Opinion Psychiatry. 2021;34(5):503-507. doi:10.1097/YCO.0000000000000733

Müller N, Krause D, Dehning S, et al. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophrenia Research. 2010;121(1-3):118-124. doi:10.1016/j.schres.2010.04.015

Kanji S, Fonseka TM, Marshe VS, et al. The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain. European Archives of Psychiatry and Clinical Neuroscience. 2018;268(1):3-15. doi:10.1007/s00406-017-0820-z

Lara-Villoslada F, Olivares M, Sierra S, et al. Beneficial effects of probiotic bacteria isolated from breast milk. The British Journal of Nutrition. 2007;98 Suppl 1:S96-S100. doi:10.1017/S0007114507832910

Szeligowski T, Yun AL, Lennox BR, et al. The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications. Frontiers in Psychiatry. 2020;11:156. doi:10.3389/fpsyt.2020.00156

Dickerson FB, Stallings C, Origoni A, et al. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. The Primary Care Companion for CNS Disorders. 2014;16(1):PCC.13m01579. doi:10.4088/PCC.13m01579

Ghaderi A, Banafshe HR, Mirhosseini N, et al. Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients. BMC Psychiatry. 2019;19(1):77. doi:10.1186/s12888-019-2059-x

Minichino A, Brondino N, Solmi M, et al. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophrenia Research. 2021;234:1-13. doi:10.1016/j.schres.2020.02.012

Tomasik J, Yolken RH, Bahn S, et al. Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial. Biomarker Insights. 2015;10:47-54. doi:10.4137/BMI.S22007

Okubo R, Koga M, Katsumata N, et al. Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. Journal of Affective Disorders. 2019;245:377-385. doi:10.1016/j.jad.2018.11.011

Forth E, Buehner B, Storer A, et al. Systematic review of probiotics as an adjuvant treatment for psychiatric disorders. Frontiers in Behavioral Neuroscience. 2023;17:1111349. doi:10.3389/fnbeh.2023.1111349

Yang Y, Long Y, Kang D, et al. Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis. Psychopharmacology. 2021;238(9):2449-2457. doi:10.1007/s00213-021-05866-z

Ng QX, Soh AYS, Venkatanarayanan N, et al. A Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia Symptoms. Neuropsychobiology. 2019;78(1):1-6. doi:10.1159/000498862

Reilly JL, Harris MS, Keshavan MS, et al. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Archives of General Psychiatry. 2006;63(11):1189-1197. doi:10.1001/archpsyc.63.11.1189

Gronier B, Savignac HM, Di Miceli M, et al. Increased cortical neuronal responses to NMDA and improved attentional set-shifting performance in rats following prebiotic (B-GOS®) ingestion. European Neuropsychopharmacology:The Journal of the European College of Neuropsychopharmacology. 2018;28(1):211-224. doi:10.1016/j.euroneuro.2017.11.001

Munawar N, Ahmad A, Anwar MA, et al. Modulation of Gut Microbial Diversity through Non-Pharmaceutical Approaches to Treat Schizophrenia. International Journal of Molecular Science. 2022;23(5):2625.doi:10.3390/ijms23052625